We serve Chemical Name:1-(3-Pyridinyl)-2-propen-1-ol CAS:144825-44-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3-Pyridinyl)-2-propen-1-ol
CAS.NO:144825-44-5
Synonyms:1-(3-Pyridyl)-2-propen-1-ol;3-Pyridylmethylamine;(+/-)-tert-butyl 1-(pyridin-3′-yl)prop-2-en-1-yl carbonate;3-Pyridinylmethanamine;3-(Aminomethyl)pyridine;Picolamine;1-(3-pyridyl)prop-2-en-1ol;3-Picolylamine;1-(pyridin-3-yl)methylamine;3-pyridinylmethylamine;pyridin-3-ylmethylamine;3-Pyridinemethylamine;1-pyridin-3-yl-prop-2-en-1-ol;1-(pyridin-3-yl)allylalcohol;3-Pyridinemethanamine
Molecular Formula:C8H9NO
Molecular Weight:135.16300
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:33.12000
Exact Mass:135.06800
LogP:1.30100
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(3-Pyridyl)-2-propen-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Pyridinemethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-pyridyl)prop-2-en-1ol Use and application,1-(3-Pyridyl)-2-propen-1-ol technical grade,usp/ep/jp grade.
Related News: GEM has also partnered with Good360 & Walmart to ensure that every relocated family has move in essentials like bedding, towels, small appliances, tableware, cutlery, glassware and cookware. In addition, each relocated family in the program will receive our GEM Bstrong, Good360, and Walmart ‘Welcome Home Kits’ consisting of new sheets, towels, silverware, pots and pans sets, small appliances and basic move in goods. Transportation of goods provided by GEM transportation partner UC Group (www.groupncs.com). 3-chloro-N-diphenoxyphosphoryl-4-methylaniline manufacturers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 4-(buta-2,3-dien-1-yl)morpholine suppliers SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. cyano(3-phenoxyphenyl)methyl 2-(2-cyclohexylethoxy)-3-methylbutanoate vendor & factory.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. cyano(3-phenoxyphenyl)methyl 2-(2-cyclohexylethoxy)-3-methylbutanoate vendor & factory.
